✦ LIBER ✦

Modified FOLFOX-6 chemotherapy in advanced gastric cancer: Results of phase II study and comprehensive analysis of polymorphisms as a predictive and prognostic marker

✍ Scribed by Bhumsuk Keam; Seock-Ah Im; Sae-Won Han; Hye Seon Ham; Min A Kim; Do-Youn Oh; Se-Hoon Lee; Jee Hyun Kim; Dong-Wan Kim; Tae-You Kim; Dae Seog Heo; Woo Ho Kim; Yung-Jue Bang

Book ID: 115011264
Publisher: BioMed Central
Year: 2008
Tongue: English
Weight: 516 KB
Volume: 8
Category: Article
ISSN: 1471-2407
DOI: 10.1186/1471-2407-8-148

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study and biomarker analysis of

Phase II study and biomarker analysis of cetuximab combined with modified FOLFOX6 in advanced gastric cancer

✍ Han, S-W; Oh, D-Y; Im, S-A; Park, S R; Lee, K-W; Song, H S; Lee, N-S; Lee, K H; 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 148 KB

Predictive and prognostic markers for th

Predictive and prognostic markers for the outcome of chemotherapy in advanced colorectal cancer, a retrospective analysis of the phase III randomised CAIRO study

✍ Miriam Koopman; Sabine Venderbosch; Harm van Tinteren; Marjolijn J. Ligtenberg; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 501 KB

A phase II study of docetaxel as salvage

A phase II study of docetaxel as salvage chemotherapy in advanced gastric cancer after failure of fluoropyrimidine and platinum combination chemotherapy

✍ Jae-Lyun Lee; Min-Hee Ryu; Heung Moon Chang; Tae-Won Kim; Jeong Hwan Yook; Sung 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 325 KB

6576 Irinotecan and low-dose capecitabin

6576 Irinotecan and low-dose capecitabine combination as first-line chemotherapy in advanced or metastatic gastric cancer: results of a phase II study

✍ Farhat, F.; Kattan, J.; Chahine, G.; Naser, F.; Youness, F.; Ghosn, M. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 49 KB

224 Docetaxel and cisplatin combination

224 Docetaxel and cisplatin combination chemotherapy in patients with advanced or metastatic gastric cancer: results of a multicentre phase II study

✍ J. Fahlke; K. Ridwelski; E. Kettner; U. Keilholz; C. Schmidt; K. Eichelmann; H. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 160 KB

Phase I/II study of a combination of doc

Phase I/II study of a combination of docetaxel, capecitabine, and cisplatin (DXP) as first-line chemotherapy in patients with advanced gastric cancer

✍ Yoon-Koo Kang; Min-Hee Ryu; Changhoon Yoo; Heung-Moon Chang; Jeong Hwan Yook; Su 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 334 KB